Regional and network-level resting state functional connectivity markers of pharmacological treatment resistance in obsessive-compulsive disorder

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Treatment resistance in obsessive-compulsive disorder (OCD) is common, with 40–60% of patients failing to respond to pharmacotherapy. Identifying functional differences between responders and non-responders may guide alternative treatment strategies. We investigated resting-state brain differences between selective serotonin reuptake inhibitor (SSRI) responders and non-responders and compared them with healthy controls (HC). 3T MRI scans were acquired from 80 participants with OCD and 50 HCs. Structural and 5-minute resting-state data were processed using the CONN toolbox. Regions showing group differences in amplitude of low-frequency fluctuation (ALFF) were identified for seed-based connectivity analysis. ANCOVA revealed significant ALFF differences among groups in the anterior middle temporal gyrus (R-aMTG) and temporal pole (R-TP). SSRI responders showed reductions in seed-to-voxel connectivity than non-responders between these regions and the left superior and inferior occipital cortices, left superior parietal lobule, and left temporo-occipital middle temporal gyrus. Responders also showed reductions in connectivity with the left superior parietal lobule compared with HCs. Across the OCD group, Y-BOCS scores positively correlated with ALFF in the R-aMTG (p=0.008) and R-TP (p=0.044). Altered temporal cortical activity and connectivity with posterior regions were associated with SSRI treatment response, supporting a role for temporal–posterior cortical networks in OCD treatment response.

Article activity feed

  1. Regional and network-level resting state functional connectivity markers of pharmacological treatment resistance in obsessive-compulsive disorder https://www.biorxiv.org/content/10.64898/2026.09.23.753814v1

  2. Regional and network-level resting state functional connectivity markers of pharmacological treatment resistance in obsessive-compulsive disorder https://www.biorxiv.org/content/10.64898/2026.09.23.753814v1